Associated Press

If someone is already pre-disposed to disbelieve scientific conclusions around issues like human evolution, climate change, stem cell research or the Big Bang theory because of their religious or political views, learning more about the subject actually increases their disbelief, a new study finds.

Why it matters: The research flies in the face of commonly held views that more science literacy and greater education around controversial scientific issues will diffuse polarization but supports a growing body of evidence about how our identity forms our views.

  • For stem cell research, the Big Bang theory and evolution, religious identity overrode science literacy.
  • Political beliefs surrounding climate change led to polarization.
  • They found little evidence (yet) of political or religious polarization for nanotechnology and genetically modified food.

What they found: Carnegie Mellon social scientists looked at Americans' beliefs around six potentially controversial issues: stem cell research, the Big Bang theory, nanotechnology, GMOs, climate change and evolution. The found people's beliefs about topics associated with their religious and political views become increasingly polarized with more education (measured by markers like the number of years in school, highest degrees earned, aptitude on general science facts or the number of science classes taken). Baruch Fischhoff from CMU said:

"These are troubling correlations. We can only speculate about the underlying causes. One possibility is that people with more education are more likely to know what they are supposed to say, on these polarized issues, in order to express their identity. Another possibility is that they have more confidence in their ability to argue their case."

One bright spot for science literacy advocates: If someone is already pre-disposed to trust the peer-reviewed science process and scientists, they're likely to believe what they say and find in all of these areas.

Go deeper: Arizona State University's Daniel Sarewitz got to the heart of it in the Guardian yesterday.

Go deeper

Updated 52 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Global: Total confirmed cases as of 8 p.m. ET: 20,188,678 — Total deaths: 738,668 — Total recoveries: 12,452,126Map.
  2. U.S.: Total confirmed cases as of 8 p.m. ET: 5,138,850 — Total deaths: 164,480 — Total recoveries: 1,714,960 — Total tests: 63,252,257Map.
  3. States: Georgia reports 137 coronavirus deaths, setting new daily record Florida reports another daily record for deaths.
  4. Health care: Trump administration buys 100 million doses of Moderna's coronavirus vaccine.
  5. Business: Moderna reveals it may not hold patent rights for vaccine.
  6. Sports: Big Ten scraps fall football season.

Voters cast ballots in Minnesota, Georgia, Connecticut, Wisconsin and Vermont

Photo: Spencer Platt/Getty Images

Primary elections are being held on Tuesday in Minnesota, Georgia, Connecticut, Vermont and Wisconsin.

The big picture: Georgia and Wisconsin both struggled to hold primaries during the coronavirus pandemic, but are doing so again — testing their voting systems ahead of the general election. Rep. Ilhan Omar (D-Minn.) is facing a strong challenger as she fights for her political career. In Georgia, a Republican primary runoff pits a QAnon supporter against a hardline conservative.

3 hours ago - Health

Trump administration buys 100 million doses of Moderna's vaccine

A volunteer in Moderna's vaccine clinical trial receives a shot. Photo: Paul Hennessy/NurPhoto via Getty Images

The U.S. government has agreed to buy 100 million doses of Moderna's experimental coronavirus vaccine for $1.5 billion, or $15 per dose.

Why it matters: The Trump administration, through Operation Warp Speed, has now bought initial batches of vaccines from Moderna, GlaxoSmithKline and Sanofi, Pfizer, Novavax, Johnson & Johnson and AstraZeneca before knowing whether they are safe and effective. The federal government also appears to own some of the patent rights associated with Moderna's vaccine.